Paper42872064PubMed
HMGB1 functional plasticity in neurodegenerative diseases and its translational implications.
Cai W and 7 others. Front Immunol, 2026.
Cite this record
ConductScience Library. HMGB1 functional plasticity in neurodegenerative diseases and its translational implications. Papers, record 42872064. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42872064
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- HMGB1 functional plasticity in neurodegenerative diseases and its translational implications.
- Journal
- Front Immunol
- Year
- 2026
- Publication types
- Journal Article, Review, Research Support, Non-U.S. Gov't
- Revised in PubMed
- 2026-10-27
Source PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HMGB1 Protein | Major topic |
| Neurodegenerative Diseases | Major topic |
| Humans | |
| Animals | |
| Translational Research, Biomedical | |
| Signal Transduction | |
| Alarmins | |
| Biomarkers |
Source PubMed
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40273909 | Transcriptional regulation by PHGDH drives amyloid pathology in Alzheimer's disease. | Cell | 2025 | https://conductscience.org/library/papers/40273909 | PubMed |
| 2 | 37571393 | Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals. | Nutrients | 2023 | https://conductscience.org/library/papers/37571393 | PubMed |
| 3 | 34253711 | Circulating HMGB1 is elevated in veterans with Gulf War Illness and triggers the persistent pro-inflammatory microglia phenotype in male C57Bl/6J mice. | Transl Psychiatry | 2021 | https://conductscience.org/library/papers/34253711 | PubMed |
| 4 | 15597044 | alpha-Synuclein filaments bind the transcriptional regulator HMGB-1. | Neuroreport | 2004 | https://conductscience.org/library/papers/15597044 | PubMed |
| 5 | 20123072 | HMGB proteins: interactions with DNA and chromatin. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/20123072 | PubMed |
| 6 | 32706028 | HMGB1 A box protects neurons by potently inhibiting both microglia and T cell-mediated inflammation in a mouse Parkinson's disease model. | Clin Sci (Lond) | 2020 | https://conductscience.org/library/papers/32706028 | PubMed |
| 7 | 23639787 | Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis. | Neurobiol Dis | 2013 | https://conductscience.org/library/papers/23639787 | PubMed |
| 8 | 35348636 | The bidirectional lung brain-axis of amyloid-β pathology: ozone dysregulates the peri-plaque microenvironment. | Brain | 2023 | https://conductscience.org/library/papers/35348636 | PubMed |
| 9 | 12765338 | Structural basis for the proinflammatory cytokine activity of high mobility group box 1. | Mol Med | 2003 | https://conductscience.org/library/papers/12765338 | PubMed |
| 10 | 38624088 | Peripheral HMGB1 is linked to O3 pathology of disease-associated astrocytes and amyloid. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/38624088 | PubMed |
| 11 | 40385486 | Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40385486 | PubMed |
| 12 | 30210286 | Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral Sclerosis. | Front Neurosci | 2018 | https://conductscience.org/library/papers/30210286 | PubMed |
| 13 | 29676481 | High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches. | J Neurochem | 2018 | https://conductscience.org/library/papers/29676481 | PubMed |
| 14 | 10398600 | HMG-1 as a late mediator of endotoxin lethality in mice. | Science | 1999 | https://conductscience.org/library/papers/10398600 | PubMed |
| 15 | 15499593 | High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity. | J Neurosci Res | 2004 | https://conductscience.org/library/papers/15499593 | PubMed |
| 16 | 36566881 | Glycyrrhizin prevents 3-nitropropionic acid-induced neurotoxicity by downregulating HMGB1/TLR4/NF-κB p65 signaling, and attenuating oxidative stress, inflammation, and apoptosis in rats. | Life Sci | 2023 | https://conductscience.org/library/papers/36566881 | PubMed |
| 17 | 18631454 | Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. | Immunity | 2008 | https://conductscience.org/library/papers/18631454 | PubMed |
| 18 | 36388178 | HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target. | Front Neurol | 2022 | https://conductscience.org/library/papers/36388178 | PubMed |
| 19 | 33876503 | Intracellular amyloid hypothesis for ultra-early phase pathology of Alzheimer's disease. | Neuropathology | 2021 | https://conductscience.org/library/papers/33876503 | PubMed |
| 20 | 31563843 | Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses. | DNA Repair (Amst) | 2019 | https://conductscience.org/library/papers/31563843 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42872064
GET https://conductscience.org/api/papers/v1/42872064/references?page=2